Platelet Aggregation Inhibitors Concept

subject area of

• 14 Antithrombotic treatment of cerebrovascular disease  Journal Articles
• 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation  Journal Articles
• 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19  Journal Articles
• CYP2C19 Genetic Testing Should Not Be Done in All Patients Treated With Clopidogrel Who Are Undergoing Percutaneous Coronary Intervention  Journal Articles
• Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Guidelines, Update 2014  Journal Articles
• Reviews: Use of Warfarin in People with Low Glomerular Filtration Rate or on Dialysis  Journal Articles
• d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy  Journal Articles
• A Barbourin-albumin Fusion Protein that Is Slowly Cleared In Vivo Retains the Ability to Inhibit Platelet Aggregation In Vitro  Journal Articles
• A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction  Journal Articles
• A National Survey of Canadian Practice Patterns of Warfarin After Anterior Wall Myocardial Infarction in the Current Era of Dual Antiplatelet Therapy  Journal Articles
• A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation  Journal Articles
• A Nurse-coordinated Model of Care versus Usual Care for Stage 3/4 Chronic Kidney Disease in the Community  Journal Articles
• A Risk Assessment Tool Incorporating New Biomarkers for Cardiovascular Events in Acute Coronary Syndromes: The Organization to Assess Strategies in Ischemic Syndromes (OASIS) Risk Score  Journal Articles
• A population‐based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors  Journal Articles
• A practical approach to prescribing antiplatelet therapy in patients with acute coronary syndromes  Journal Articles
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)  Journal Articles
• A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin  Journal Articles
• A single dose of aprotinin prevents platelet hyporeactivity after coronary artery bypass graft surgery  Journal Articles
• ADP‐stimulated fibrinogen binding is necessary for some of the inositol phospholipid changes found in ADP‐stimulated platelets  Journal Articles
• AIDA STEMI: no benefit for intracoronary abciximab  Journal Articles
• ASCEND-Eye  Journal Articles
• Abciximab in Acute Ischemic Stroke  Journal Articles
• Activated Clotting Time to Guide Heparin Dosing in Non–ST-Segment–Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors  Journal Articles
• Active metabolite concentration of clopidogrel in patients taking different doses of aspirin: results of the interaction trial  Journal Articles
• Acute Profound Thrombocytopenia Associated with Eptifibatide Therapy  Journal Articles
• Acute management of bleeding in patients on novel oral anticoagulants  Journal Articles
• Acute reversal of anticoagulant-induced bleeding complications.  Journal Articles
• Adding aspirin to clopidogrel after TIA and ischemic stroke  Journal Articles
• Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation  Journal Articles
• Advances in Antithrombotic Therapy: Novel Agents  Journal Articles
• Advances in Understanding “High on-Treatment Platelet Reactivity”  Journal Articles
• After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding  Journal Articles
• Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registry  Journal Articles
• An optimum prophylactic dose of prasugrel monotherapy may safely and effectively prevent the development of experimental thrombotic strokes  Journal Articles
• Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation  Journal Articles
• Angina (unstable).  Journal Articles
• Angina (unstable).  Journal Articles
• Angina (unstable).  Journal Articles
• Animal Models of Thrombosis From Zebrafish to Nonhuman Primates  Journal Articles
• Anti-platelet therapy and the anaesthesiologist: controversies and unresolved clinical dilemmas continue  Journal Articles
• Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add?  Journal Articles
• Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers  Journal Articles
• Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers  Journal Articles
• Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized Trials.  Journal Articles
• Anticoagulation therapy in patients with prosthetic heart valves.  Journal Articles
• Anticoagulation/platelet inhibition for atrial fibrillation  Journal Articles
• Antifibrinolytics may be cost saving among recent recipients of combined acetylsalicylic acid and clopidogrel who undergo coronary artery bypass graft surgery.  Journal Articles
• Antiplatelet Agents in Acute Coronary Syndromes  Journal Articles
• Antiplatelet Drugs  Journal Articles
• Antiplatelet Drugs  Journal Articles
• Antiplatelet Effect of Active Components Derived from Chinese Herbal Medicine  Journal Articles
• Antiplatelet Therapy and Cardiac Surgery: Review of Recent Evidence and Clinical Implications  Journal Articles
• Antiplatelet Therapy and Coronary Artery Bypass Grafting: Analysis of Current Evidence With a Focus on Acute Coronary Syndrome  Journal Articles
• Antiplatelet Therapy for Secondary Prevention of Noncardioembolic Ischemic Stroke  Journal Articles
• Antiplatelet Therapy in Cerebral Small Vessel Disease  Journal Articles
• Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention  Journal Articles
• Antiplatelet Therapy versus Anticoagulation after Surgical Bioprosthetic Aortic Valve Replacement: A Systematic Review and Meta-Analysis  Journal Articles
• Antiplatelet drugs  Journal Articles
• Antiplatelet therapy and coronary artery bypass grafting  Journal Articles
• Antiplatelet therapy and coronary artery bypass grafting: a systematic review and network meta-analysis  Journal Articles
• Antiplatelet therapy and incident cognitive impairment or dementia—a systematic review and meta-analysis of randomised clinical trials  Journal Articles
• Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial  Journal Articles
• Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks  Journal Articles
• Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks  Journal Articles
• Antiplatelet therapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. Key messages for clinical practice  Journal Articles
• Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials  Journal Articles
• Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease  Journal Articles
• Antiplatelet therapy in prevention of cardio- and venous thromboembolic events  Journal Articles
• Antiplatelet therapy in the management of atherothrombosis: recent clinical advances  Journal Articles
• Antiplatelet use in patients with essential thrombocythemia: A survey of opinion and Canadian practice  Journal Articles
• Antiplatelet versus oral anticoagulant therapy as antithrombotic prophylaxis after mitral valve repair  Journal Articles
• Antithrombotic Agents  Journal Articles
• Antithrombotic Agents in Coronary Artery Disease  Journal Articles
• Antithrombotic Agents in Coronary Artery Disease  Journal Articles
• Antithrombotic Strategies for Patients With Peripheral Artery Disease: JACC Scientific Statement.  Journal Articles
• Antithrombotic Therapy for Cerebrovascular Disorders  Journal Articles
• Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes  Journal Articles
• Antithrombotic Therapy in Neonates and Children  Journal Articles
• Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty  Journal Articles
• Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention  Journal Articles
• Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention  Journal Articles
• Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention  Journal Articles
• Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves  Journal Articles
• Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts Following Percutaneous Transluminal Coronary Angioplasty  Journal Articles
• Antithrombotic Therapy in Peripheral Artery Disease: Risk Stratification and Clinical Decision Making  Journal Articles
• Antithrombotic Treatment at Onset of Stroke with Atrial Fibrillation, Functional Outcome, and Fatality: A Systematic Review and Meta-Analysis  Journal Articles
• Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation: Drugs and Doses  Journal Articles
• Antithrombotic actions of statins.  Journal Articles
• Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Journal Articles
• Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleeding  Journal Articles
• Antithrombotic management of patients with deep vein thrombosis and venous stents: an international registry  Journal Articles
• Antithrombotic therapies in Canadian atrial fibrillation patients with concomitant coronary artery disease: Insights from the CONNECT AF + PCI-II program  Journal Articles
• Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves  Journal Articles
• Antithrombotic therapy in aortic diseases: A narrative review  Journal Articles
• Antithrombotic therapy in atrial fibrillation.  Journal Articles
• Antithrombotic therapy in peripheral artery disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Journal Articles
• Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis  Journal Articles
• Antithrombotic treatment beyond 1 year after percutaneous coronary intervention in patients with atrial fibrillation  Journal Articles
• Antithrombotics in stable peripheral artery disease  Journal Articles
• Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial.  Journal Articles
• Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome  Journal Articles
• Applying contemporary antithrombotic therapy in the secondary prevention of chronic atherosclerotic cardiovascular disease  Journal Articles
• Approche pratique à la prescription des antiplaquettaires chez les patients atteints de syndromes coronariens  Journal Articles
• Appropriate Assessment of the Functional Consequences of Platelet Cyclooxygenase-1 Inhibition by Aspirin in vivo  Journal Articles
• Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.  Journal Articles
• Are P2Y12 inhibitors superior to aspirin for long-term secondary prevention of cardiovascular disease?  Journal Articles
• Are all P2Y12 equally effective in vein graft angioplasty? A report from the UK database  Journal Articles
• Aspirin  Journal Articles
• Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty  Journal Articles
• Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke  Journal Articles
• Aspirin and Other Platelet-Active Drugs  Conferences
• Aspirin and clopidogrel in patients with ACS undergoing PCI: CURE and PCI-CURE.  Journal Articles
• Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects  Journal Articles
• Aspirin and other platelet-active drugs. The relationship among dose, effectiveness, and side effects.  Journal Articles
• Aspirin for Acute Coronary Syndromes: Have We Learned the Correct Dose Yet?  Journal Articles
• Aspirin for Dual Prevention of Venous and Arterial Thrombosis  Journal Articles
• Aspirin for Preventing Venous Thromboembolism  Journal Articles
• Aspirin for Prevention and Treatment of Cardiovascular Disease  Journal Articles
• Aspirin for preventing venous thromboembolism.  Journal Articles
• Aspirin for preventing venous thromboembolism.  Journal Articles
• Aspirin for the Prevention of Recurrent Venous Thromboembolism  Journal Articles
• Aspirin in Patients Undergoing Noncardiac Surgery  Journal Articles
• Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery  Journal Articles
• Aspirin in secondary prevention of recurrent venous thromboembolism  Journal Articles
• Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty  Journal Articles
• Aspirin plus clopidogrel was not linked to risk for cancer compared with aspirin alone or no antiplatelets  Journal Articles
• Aspirin resistance  Journal Articles
• Aspirin resistance: Table 1  Journal Articles
• Aspirin resistance: does it exist and is it an important clinical problem?  Journal Articles
• Aspirin response variability after major orthopedic surgery  Journal Articles
• Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding  Journal Articles
• Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: Insights from the Global Registry of Acute Coronary Events  Journal Articles
• Atorvastatin Delays Murine Platelet Activation In Vivo Even in the Absence of Endothelial NO Synthase  Journal Articles
• Atrial Fibrillation and PCI — Do We Still Need Aspirin?  Journal Articles
• Atrial Fibrillation in Patients with Cryptogenic Stroke  Journal Articles
• Atrial fibrillation and stroke: how much atrial fibrillation is enough to cause a stroke?  Journal Articles
• Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data  Journal Articles
• Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.  Journal Articles
• BF061, a novel antiplatelet and antithrombotic agent targeting P2Y12 receptor and phosphodiesterase  Journal Articles
• Benefit of Clopidogrel in Patients With Acute Coronary Syndromes Without ST-Segment Elevation in Various Risk Groups  Journal Articles
• Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range  Journal Articles
• Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: Further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study  Journal Articles
• Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia  Journal Articles
• Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome  Journal Articles
• Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin  Journal Articles
• Beyond Heparin and Aspirin  Journal Articles
• Bivalirudin  Journal Articles
• Bleeding Complications in Patients with Acute Coronary Syndromes: Are They Important and How Can We Prevent Them?  Journal Articles
• Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin  Journal Articles
• Bleeding Risks With Non-Vitamin K Oral Anticoagulants Versus Single Antiplatelet Therapy : A Systematic Review and Meta-analysis of Randomized Trials.  Journal Articles
• Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis  Journal Articles
• Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta‐analysis  Journal Articles
• CAPRIE trial.  Journal Articles
• COMPASS for Vascular Surgeons  Journal Articles
• COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up  Journal Articles
• Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease  Journal Articles
• Canadian Cardiovascular Society Guidelines for the Diagnosis and Management of Stable Ischemic Heart Disease  Journal Articles
• Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology 2023 Focused Update of the Guidelines for the Use of Antiplatelet Therapy  Journal Articles
• Canadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy  Journal Articles
• Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention  Journal Articles
• Cangrelor: a new CHAMPION for percutaneous coronary intervention  Journal Articles
• Cerebral microbleeds and asundexian in non-cardioembolic ischemic stroke: Secondary analyses of the PACIFIC-STROKE randomized trial  Journal Articles
• Cervical artery dissection: Pathology, epidemiology and management  Journal Articles
• Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial  Journal Articles
• Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source  Journal Articles
• Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry  Journal Articles
• Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial  Journal Articles
• Clinical Studies: Evidence for Intervention with Specific Antiplatelet Drugs in Arterial Thromboembolism  Journal Articles
• Clinical decisions. Management of stable coronary disease.  Journal Articles
• Clinical potential of antithrombotic drugs in coronary syndromes  Journal Articles
• Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI)  Journal Articles
• Clopidogrel Resistance  Journal Articles
• Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events  Journal Articles
• Clopidogrel and percutaneous coronary intervention  Journal Articles
• Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes  Journal Articles
• Clopidogrel plus aspirin in atrial fibrillation.  Journal Articles
• Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis  Journal Articles
• Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial  Journal Articles
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients  Journal Articles
• Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease  Journal Articles
• Combination Antithrombotic Therapy for Reduction of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease.  Conferences
• Combination Therapy to Prevent Cardiovascular Disease  Journal Articles
• Combination warfarin-ASA therapy: Which patients should receive it, which patients should not, and why?  Journal Articles
• Combined Aspirin–Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease  Journal Articles
• Combined antiplatelet and anticoagulant therapy: clinical benefits and risks  Conferences
• Combined warfarin–aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?  Journal Articles
• Comparative Benefits of Clopidogrel and Aspirin in High-Risk Patient Populations  Journal Articles
• Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa (αIIb/β3) receptor-directed platelet inhibition  Journal Articles
• Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition  Journal Articles
• Comparison of Dual-antiplatelet Therapy to Mono-antiplatelet Therapy After Transcatheter Aortic Valve Implantation: Systematic Review and Meta-analysis  Journal Articles
• Comparison of High-Dose With Low-Dose Aspirin in Patients With Mechanical Heart Valve Replacement Treated With Oral Anticoagulant  Journal Articles
• Comparison of Risk Factor Reduction and Tolerability of a Full-Dose Polypill (With Potassium) Versus Low-Dose Polypill (Polycap) in Individuals at High Risk of Cardiovascular Diseases  Journal Articles
• Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non–Q-wave myocardial infarction undergoing percutaneous coronary intervention  Journal Articles
• Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the organization to assess strategies in acute ischemic syndromes (OASIS)‐5 trial  Journal Articles
• Comparison of the effect of coagulation and platelet function impairments on various mouse bleeding models  Journal Articles
• Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II  Journal Articles
• Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial  Journal Articles
• Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial  Journal Articles
• Concurrent Lower Gastrointestinal Bleeding Risk and Myocardial Ischemic Risk: Resume Aspirin or Not?  Journal Articles
• Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting  Journal Articles
• Contemporary use of guideline‐based higher potency P2Y12 receptor inhibitor therapy in patients with moderate‐to‐high risk non‐ST‐segment elevation myocardial infarction: Results from the Canadian ACS reflective II cross‐sectional study  Journal Articles
• Coronary artery stenting in patients treated by clopidogrel without aspirin  Journal Articles
• Cost-Effectiveness Analysis of a Randomized Trial Comparing Care Models for Chronic Kidney Disease  Journal Articles
• Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND)  Journal Articles
• Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: A long-term analysis based on the CURE trial  Journal Articles
• Cost‐effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long‐term model based on the cure trial  Journal Articles
• Current Evidence for Genetic Testing in Clopidogrel-Treated Patients Undergoing Coronary Stenting  Journal Articles
• Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin  Journal Articles
• Decreasing Mortality With Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction: The Mayo Clinic Experience From 1991 Through 1997  Conferences
• Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients  Journal Articles
• Delayed educational reminders for long-term medication adherence in ST-elevation myocardial infarction (DERLA-STEMI): Protocol for a pragmatic, cluster-randomized controlled trial  Journal Articles
• Design and rationale of CURRENT-OASIS 7: A randomized, 2 × 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non–ST-elevation acute coronary syndromes managed with an early invasive strategy  Journal Articles
• Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non–ST-segment elevation acute coronary syndromes with a planned early invasive strategy  Journal Articles
• Design, Progress and Challenges of a Double-Blind Trial of Warfarin versus Aspirin for Symptomatic Intracranial Arterial Stenosis  Journal Articles
• Determining the price for pharmaceuticals in Germany: comparing a shortcut for IQWiG's efficiency frontier method with the price set by the manufacturer for ticagrelor  Journal Articles
• Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet‐mediated events during thrombus formation  Journal Articles
• Differences in Ischemic and Hemorrhagic Recurrence Rates among Race-Ethnic Groups in the PRoFESS Secondary Stroke Prevention Trial  Journal Articles
• Different perspective on ASA use.  Journal Articles
• Discordance Between Physicians' Estimation of Patient Cardiovascular Risk and Use of Evidence-Based Medical Therapy  Journal Articles
• Do Patients with Acute Myocardial Infarction Benefit from Treatment with Clopidogrel?  Journal Articles
• Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism?  Journal Articles
• Does prior use of antiplatelet therapy modify the effect of dual antiplatelet therapy in transient ischaemic attack/minor ischaemic stroke: A systematic review and meta‐analysis  Journal Articles
• Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes  Journal Articles
• Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial  Journal Articles
• Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention  Journal Articles
• Drug Therapies in the Secondary Prevention of Cardiovascular Diseases:Successes, Shortcomings and Future Directions  Journal Articles
• Dual Antiplatelet Therapy After Percutaneous Coronary Intervention  Journal Articles
• Dual Pathway Inhibition for Vascular Protection in Patients with Atherosclerotic Disease: Rationale and Review of the Evidence  Journal Articles
• Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: A position statement of the Canadian Cardiovascular Society  Journal Articles
• Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline  Journal Articles
• Dual antiplatelets for 30 mo after drug-eluting stents reduced stent thrombosis and CV and cerebrovascular events  Journal Articles
• Dual pathway inhibition for atherosclerotic cardiovascular disease: Recent advances  Journal Articles
• Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease  Journal Articles
• Duration of dual antiplatelet therapy and associated outcomes following percutaneous coronary intervention for acute myocardial infarction: contemporary practice insights from the Canadian Observational Antiplatelet Study  Journal Articles
• Early Recovery and Functional Outcome are Related with Causal Stroke Subtype: Data from the Tinzaparin in Acute Ischemic Stroke Trial  Journal Articles
• Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes  Journal Articles
• Early high-dose rosuvastatin prevented contrast-induced acute kidney injury in non–ST-elevation ACS  Journal Articles
• Economic issues in glycoprotein IIb/IIIa receptor therapy  Journal Articles
• Effect of Addition of Clopidogrel to Aspirin on Stroke Incidence: Meta-Analysis of Randomized Trials  Journal Articles
• Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation  Journal Articles
• Effect of Combined Aspirin and Extended-Release Dipyridamole Versus Clopidogrel on Functional Outcome and Recurrence in Acute, Mild Ischemic Stroke  Journal Articles
• Effect of Different Doses of Acetylsalicylic Acid on the Antithrombotic Activity of Clopidogrel in a Mouse Arterial Thrombosis Model  Journal Articles
• Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma  Journal Articles
• Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention  Journal Articles
• Effect of PCI on Quality of Life in Patients with Stable Coronary Disease  Journal Articles
• Effect of Peripheral Interventions in Patients with Peripheral Artery Disease Receiving Rivaroxaban and Aspirin: Analyses from the XATOA Registry  Journal Articles
• Effect of abciximab on late adverse events in patients with diabetes mellitus undergoing stent implantation  Journal Articles
• Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study  Journal Articles
• Effect of aspirin in vascular surgery in patients from a randomized clinical trial (POISE-2)  Journal Articles
• Effect of desmopressin on hematoma expansion in antiplatelet-associated intracerebral hemorrhage: A systematic review and meta-analysis  Journal Articles
• Effectiveness and safety of abciximab after failed thrombolytic therapy  Journal Articles
• Effectiveness and safety of combined antiplatelet and anticoagulant therapy: A critical review of the evidence from randomized controlled trials  Journal Articles
• Effectiveness of platelet inhibition on major adverse cardiac events in non-cardiac surgery after percutaneous coronary intervention: a prospective cohort study  Journal Articles
• Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes  Journal Articles
• Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation  Journal Articles
• Effects of Ethanol on Pathways of Platelet Aggregation In Vitro  Journal Articles
• Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial  Journal Articles
• Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: an argument for a different DP receptor?  Journal Articles
• Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study  Journal Articles
• Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study  Journal Articles
• Effects of ibrutinib on in vitro platelet aggregation in blood samples from healthy donors and donors with platelet dysfunction  Journal Articles
• Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial  Journal Articles
• Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study  Journal Articles
• Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension  Journal Articles
• Effects of ticagrelor versus clopidogrel on platelet function in fibrinolytic-treated STEMI patients undergoing early PCI  Journal Articles
• Effects ofCYP2C19Genotype on Outcomes of Clopidogrel Treatment  Journal Articles
• Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines  Journal Articles
• Efficacy and Safety of Warfarin VS. Antiplatelet Therapy in Patients with Systolic Heart Failure and Sinus Rhythm: A Systematic Review and Meta-Analysis of Randomized Controlled Trials  Journal Articles
• Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial  Journal Articles
• Efficacy and safety of cilostazol based triple antiplatelet treatment versus dual antiplatelet treatment in patients undergoing coronary stent implantation: an updated meta-analysis of the randomized controlled trials  Journal Articles
• Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use  Journal Articles
• Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease  Journal Articles
• Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a “CASPAR like” outcome from VOYAGER PAD  Journal Articles
• Efficacy of Antiplatelet Therapy in Secondary Prevention Following Lacunar Stroke  Journal Articles
• Eicosapentaenoic Acid Interferes with U46619-Stimulated Formation of Inositol Phosphates in Washed Rabbit Platelets  Journal Articles
• Embolization of the deep cervical collaterals—a unique endovascular approach to prevent repeated posterior fossa strokes refractory to medical therapy  Journal Articles
• Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial  Journal Articles
• Ethanol enhances the inhibitory effect of an oral GPIIb/IIIa antagonist on human platelet function  Journal Articles
• European and Australian stroke prevention in reversible ischaemia trial (ESPRIT) study group  Journal Articles
• Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials  Journal Articles
• Evaluation of the role of abciximab (Reopro) as a rescue agent during percutaneous coronary interventions: In-hospital and six-month outcomes  Journal Articles
• Executive Summary  Journal Articles
• Expert Consensus Document on the Use of Antiplatelet Agents The Task Force on the Use of Antiplatelet Agents in Patients with Atherosclerotic Cardiovascular Disease of the European Society of Cardiology  Journal Articles
• Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials  Journal Articles
• Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial  Journal Articles
• Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards  Journal Articles
• Fifty years of research on antithrombotic therapy: Achievements and disappointments  Journal Articles
• Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis  Journal Articles
• Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy  Journal Articles
• From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes The Global Registry of Acute Coronary Events (GRACE)  Journal Articles
• G-Protein–Coupled Receptors as Signaling Targets for Antiplatelet Therapy  Journal Articles
• GPIIb/IIIa Inhibitors in Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction - Less Is More?  Journal Articles
• Glycoprotein IIb/IIIa Receptor Therapy in Percutaneous Coronary Intervention and Non???ST-Segment Elevation Acute Coronary Syndromes  Journal Articles
• Good practice statements for antithrombotic therapy in the management of COVID‐19: Guidance from the SSC of the ISTH  Journal Articles
• Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week  Journal Articles
• Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation.  Journal Articles
• HEART FAILURE SOCIETY OF AMERICA (HFSA) PRACTICE GUIDELINES  Journal Articles
• HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches  Journal Articles
• Heart failure.  Journal Articles
• Heart failure.  Journal Articles
• Heparin-induced thrombocytopenia and the anesthesiologist.  Journal Articles
• Heparin‐induced thrombocytopenia: a prospective study on the incidence, platelet‐activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes  Journal Articles
• High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source  Journal Articles
• How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch  Journal Articles
• How can the results of the COMPASS trial benefit patients with coronary or peripheral artery disease in Poland?  Journal Articles
• How good is aspirin for patients with acute brain ischaemia?  Journal Articles
• IIb or not IIb: When, how, and which GP IIb/IIIa inhibitor?  Journal Articles
• ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction  Journal Articles
• ISTH guidelines for antithrombotic treatment in COVID‐19  Journal Articles
• Identifying and Treating Young Patients at Risk for Cardiovascular Events  Journal Articles
• Identifying the highest risk vascular patients: Insights from the XATOA registry  Journal Articles
• Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease  Journal Articles
• Impact of Evidence‐Based Stroke Care on Patient Outcomes: A Multilevel Analysis of an International Study  Journal Articles
• Impact of Frailty on the Benefits of Dual Pathway Inhibition for the Secondary Prevention of Cardiovascular Events in the COMPASS Randomised Trial  Journal Articles
• Impact of Insulin Receptor Substrate‐1 rs956115 and CYP2C19 rs4244285 Genotypes on Clinical Outcome of Patients Undergoing Percutaneous Coronary Intervention  Journal Articles
• Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban  Journal Articles
• Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Platelet Reactivity and Early Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention and Treated With Aspirin and Clopidogrel  Journal Articles
• Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE])  Journal Articles
• Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry  Journal Articles
• Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta‐analysis  Journal Articles
• Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial  Journal Articles
• Impact of provincial and national implementation strategies on P2Y12 inhibitor utilization for acute coronary syndrome in the elderly: an interrupted time series analysis from 2008 to 2018  Journal Articles
• In ACS with planned invasive evaluation, prasugrel vs ticagrelor reduced a composite of death, MI, or stroke at 1 y  Journal Articles
• In Vitro Effects of Ethanol on Rabbit Platelet Aggregation, Secretion of Granule Contents, and Cyclic AMP Levels in the Presence of Prostacyclin  Journal Articles
• In Vitro Reversal of the Anti-Aggregant Effect of Ticagrelor Using Untreated Platelets  Journal Articles
• In patients receiving DAPT after coronary stents, the PRECISE-DAPT score predicted bleeding moderately well  Journal Articles
• In patients with ESUS, the effects of OAC and antiplatelet therapy on recurrent ischemic stroke differ across subgroups at 1 to 5 y.  Journal Articles
• In vitro effects of ethanol on rabbit platelet aggregation, secretion of granule contents, and cyclic AMP levels in the presence of prostacyclin.  Journal Articles
• Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low‐dose rivaroxaban, or the combination: Secondary analysis of the COMPASS randomised controlled trial  Journal Articles
• Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in Patients Taking Oral Anticoagulation or Combined Antiplatelet Therapy  Journal Articles
• Increased Uptake of Guideline-Recommended Oral Antiplatelet Therapy: Insights from the Canadian Acute Coronary Syndrome Reflective  Journal Articles
• Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children  Conferences
• Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel  Journal Articles
• Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation  Journal Articles
• Independent predictors of stroke in patients with atrial fibrillation  Journal Articles
• Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention  Journal Articles
• Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women  Journal Articles
• Inhibition of Microsurgical Thrombosis by the Platelet Glycoprotein IIb/IIIa Antagonist SR121566A  Journal Articles
• Inhibition of platelet-dependent prothrombinase activity and thrombin generation by glycoprotein IIb/IIIa receptor-directed antagonists: potential contributing mechanism of benefit in acute coronary syndromes.  Journal Articles
• Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction  Journal Articles
• Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia  Journal Articles
• Insights into the role of thrombin in the pathogenesis of recurrent ischaemia after acute coronary syndrome  Journal Articles
• Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on‐treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)‐2 Trial  Journal Articles
• Intensity and Quality of Warfarin Anticoagulation in Chinese Patients  Journal Articles
• Interaction of low molecular weight heparin with ketorolac  Journal Articles
• International Perspectives on the Impact of the COVID-19 Pandemic on Adherence to Prescribed Dual Antiplatelet Therapy: A Window Into Acute Cardiovascular Care  Journal Articles
• International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis  Journal Articles
• Interruption of Warfarin Anticoagulation for Dental Surgery: Response  Journal Articles
• Interventions supporting long term adherence and decreasing cardiovascular events after myocardial infarction (ISLAND): pragmatic randomised controlled trial  Journal Articles
• Intracranial Haemorrhage in Patients on Antithrombotics: Clinical Presentation and Determinants of Outcome in a Prospective Multicentric Study in Italian Emergency Departments  Journal Articles
• Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy  Journal Articles
• Intracranial bleeding: epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia.  Journal Articles
• Is Daily Low-Dose Aspirin Safe to Take Following Laparoscopic Roux-en-Y Gastric Bypass for Obesity Surgery?  Journal Articles
• Is There Still a Role for Dual Antiplatelet Therapy in the Secondary Prevention of Lacunar Stroke?  Journal Articles
• Is it safe to use a proton pump inhibitor with clopidogrel?  Journal Articles
• Is there a benefit of low-dose aspirin in assisted reproduction?  Journal Articles
• Is there a role for laboratory testing to identify patients at risk of aspirin treatment failure?  Journal Articles
• Is there a role for laboratory testing to identify patients at risk of aspirin treatment failure?  Journal Articles
• Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy  Journal Articles
• Issues in the management of antiplatelet therapy in patients undergoing surgical revascularization. A roundtable discussion.  Journal Articles
• Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation  Journal Articles
• Landmark trials in thrombotic vascular disease: a critical appraisal of potential practice-changing trials in 2016–2017  Journal Articles
• Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin  Journal Articles
• Level of Systolic Blood Pressure Within the Normal Range and Risk of Recurrent Stroke  Journal Articles
• Life and limb protection with dual anti-thrombotic pathway inhibition: COMPASS ushers in a new day in atherothrombotic risk reduction  Journal Articles
• Long-Term Oral Anticoagulant Therapy in Patients With Unstable Angina or Suspected Non–Q-Wave Myocardial Infarction  Journal Articles
• Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction  Journal Articles
• Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation  Journal Articles
• Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation  Journal Articles
• Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation  Journal Articles
• Long-term outcomes after acute myocardial infarction in countries with different socioeconomic environments: an international prospective cohort study  Journal Articles
• Long-term pharmacodynamic effects of Ticagrelor versus Clopidogrel in fibrinolytic-treated STEMI patients undergoing early PCI  Journal Articles
• Longer- Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement  Journal Articles
• Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudy  Journal Articles
• Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.  Journal Articles
• Low rates of preventive practices in patients with peripheral vascular disease.  Journal Articles
• Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism  Journal Articles
• Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD  Journal Articles
• Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients After Lower Extremity Revascularization.  Journal Articles
• Low-dose Rivaroxaban Plus Aspirin for the Prevention of Cardiovascular Events: an Evaluation of COMPASS  Journal Articles
• Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial  Journal Articles
• Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials  Journal Articles
• Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial  Journal Articles
• Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.  Journal Articles
• Low-molecular-weight heparins in non–ST-segment elevation ischemia: the ESSENCE trial  Conferences
• Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease  Journal Articles
• Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin  Journal Articles
• Management of Patients on Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Peri-Endoscopic Period: A Clinical Practice Guideline Dissemination Tool  Journal Articles
• Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy  Journal Articles
• Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures  Journal Articles
• Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures  Journal Articles
• Marital status and outcomes after myocardial infarction: Observations from the Canadian Observational Antiplatelet Study (COAPT)  Journal Articles
• Meeting report ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007  Journal Articles
• Meta‐analysis: colonoscopic post‐polypectomy bleeding in patients on continued clopidogrel therapy  Journal Articles
• Microbleeds in the Secondary Prevention of Small Subcortical Strokes Trial: Stroke, mortality, and treatment interactions  Journal Articles
• Mortality Benefit in the Compass Trial: is It Related to Superior Statistical Power Or Better Efficacy and safety?  Journal Articles
• Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease  Journal Articles
• Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W  Journal Articles
• Multiple daily doses of acetyl‐salicylic acid (ASA) overcome reduced platelet response to once‐daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial  Journal Articles
• Myocardial Infarction in Neonates: A Review of an Entity with Significant Morbidity and Mortality  Journal Articles
• Myocardial Infarction, Peptic Ulcer and Acetylsalicylic Acid: Of Good and Evil  Journal Articles
• Myocardial injury after noncardiac surgery  Journal Articles
• Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable  Journal Articles
• Net clinical benefit of extended dual pathway inhibition according to baseline risk in patients with chronic coronary syndrome: a COMPASS substudy  Journal Articles
• New Antithrombotic Agents  Journal Articles
• New Antithrombotic Drugs  Journal Articles
• New Antithrombotic Drugs  Journal Articles
• New Antithrombotics  Journal Articles
• New anticoagulant strategies.  Journal Articles
• New anticoagulants in atrial fibrillation management  Conferences
• New antithrombotic agents—insights from clinical trials  Journal Articles
• Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial  Journal Articles
• Off-pump coronary artery bypass grafting attenuates postoperative bleeding associated with preoperative clopidogrel administration.  Conferences
• Once versus twice daily aspirin after coronary bypass surgery: a randomized trial  Journal Articles
• One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trial  Journal Articles
• Optimal Medical Therapy with or without PCI for Stable Coronary Disease  Journal Articles
• Optimal Medical Therapy, Lifestyle Intervention, and Secondary Prevention Strategies for Cardiovascular Event Reduction in Ischemic Heart Disease  Journal Articles
• Optimizing the Use of Abciximab and Intracoronary Stents in Patients with Acute ST Elevation Myocardial Infarction  Journal Articles
• Oral Anticoagulant Therapy in Patients With Coronary Artery Disease: A Meta-analysis  Journal Articles
• Oral Anticoagulant Therapy in Patients with Coronary Artery Disease  Journal Articles
• Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease  Journal Articles
• Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery Disease, and Peripheral Arterial Disease  Journal Articles
• Oral anticoagulant use in addition to antiplatelet therapy for secondary prevention in acute coronary syndrome: current perspectives  Journal Articles
• Oral anticoagulants and non-cardioembolic stroke prevention  Journal Articles
• Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis – Task Force on Anticoagulants in Heart Disease  Journal Articles
• Oral anticoagulants in patients with coronary artery disease  Journal Articles
• Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks  Journal Articles
• Oral antiplatelet therapy.  Journal Articles
• Oral factor Xa inhibitors and risk of subdural hematoma  Journal Articles
• Oral factor xia inhibitor milvexian after a recent acute coronary syndrome: Rationale and design of the phase 3 (Librexia ACS).  Journal Articles
• Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation  Journal Articles
• Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF  Journal Articles
• Overexpression of the Multidrug Resistance Protein-4 Transporter in Patients Undergoing Coronary Artery Bypass Graft Surgery  Journal Articles
• Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction  Journal Articles
• P2Y12 receptor inhibitor resistance and coronary artery disease  Journal Articles
• P_2x‐purinoceptors of myenteric neurones from the guinea‐pig ileum and their unusual pharmacological properties  Journal Articles
• PPI co‐therapy did not adversely affect outcomes in clopidogrel users  Journal Articles
• Panax notoginseng saponin is superior to aspirin in inhibiting platelet adhesion to injured endothelial cells through COX pathway in vitro  Journal Articles
• Panax quinquefolium saponin combined with dual antiplatelet drugs inhibits platelet adhesion to injured HUVECs via PI3K/AKT and COX pathways  Journal Articles
• Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence  Journal Articles
• Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline  Journal Articles
• Patients with Peripheral Artery Disease in the COMPASS Trial  Journal Articles
• Patterns of medical therapy in patients with peripheral artery disease in a tertiary care centre in Canada  Journal Articles
• Perioperative Aspirin and Clonidine and Risk of Acute Kidney Injury  Journal Articles
• Perioperative Management of Antiplatelet Therapy in Patients With a Coronary Stent Who Need Noncardiac Surgery  Journal Articles
• Perioperative Management of Antithrombotic Therapy  Journal Articles
• Perioperative Management of Antithrombotic Therapy  Journal Articles
• Perioperative Management of Patients Having Noncardiac Surgery Who Are Receiving Anticoagulant or Antiplatelet Therapy: An Evidence-Based but Practical Approach  Journal Articles
• Perioperative Management of Patients Receiving Anticoagulant or Antiplatelet Therapy: A Clinician-Oriented and Practical Approach  Journal Articles
• Perioperative Treatment With Aspirin or Clonidine and Risk of Acute Kidney Injury—Reply  Journal Articles
• Perioperative antithrombotic (antiplatelet and anticoagulant) therapy in urological practice: a critical assessment and summary of the clinical practice guidelines  Journal Articles
• Perioperative management and outcomes in patients receiving low-dose rivaroxaban and/or aspirin: a subanalysis of the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial  Journal Articles
• Perioperative management of antithrombotic therapy: a case-based narrative review  Journal Articles
• Perioperative management of patients who are receiving antiplatelet therapy: a case-based, evidence-informed approach  Journal Articles
• Peripheral arterial disease.  Journal Articles
• Peripheral arterial disease.  Journal Articles
• Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications  Journal Articles
• Periphere arterielle Verschlusskrankheit (PAVK)  Journal Articles
• Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH  Journal Articles
• Peri‐procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH  Journal Articles
• Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis  Journal Articles
• Pharmacogenetics of Antiplatelets and Anticoagulants: A Report on Clopidogrel, Warfarin and Dabigatran  Journal Articles
• Pharmacogenetics of Stroke  Journal Articles
• Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research  Journal Articles
• Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future  Journal Articles
• Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry  Journal Articles
• Platelet function analyzer (PFA)‐100® closure time in the evaluation of platelet disorders and platelet function  Journal Articles
• Platelet-Active Drugs  Journal Articles
• Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects  Journal Articles
• Platelet-active drugs : the relationships among dose, effectiveness, and side effects.  Journal Articles
• Platelet-active drugs: the relationships among dose, effectiveness, and side effects.  Journal Articles
• Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment  Journal Articles
• Point-of-care Testing for Assessment of Adequacy of Oral Antiplatelet Therapy in Patients With Cardiovascular Disease  Journal Articles
• Polymerizing Fibrin Decreases the Polyphosphoinositides in Chymotrypsin‐Treated Human Platelets  Journal Articles
• Polypill with or without Aspirin in Persons without Cardiovascular Disease  Journal Articles
• Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort study  Journal Articles
• Pre-Hospital Cardiac Arrest in Acute Coronary Syndromes: Insights from the Global Registry of Acute Coronary Events and the Canadian Registry of Acute Coronary Events  Journal Articles
• Preadmission Antiplatelet Use and Associated Outcomes and Costs Among ICU Patients With Intracranial Hemorrhage  Journal Articles
• Predictors of Mortality in Patients With Atrial Fibrillation (from the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events [ACTIVE A])  Journal Articles
• Predictors of Mortality in Patients With Lacunar Stroke in the Secondary Prevention of Small Subcortical Strokes Trial  Journal Articles
• Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF  Journal Articles
• Preventing Thromboembolism in Patients with Prosthetic Heart Valves  Journal Articles
• Prevention and Management of Urgent/Emergent Limb Ischemia  Journal Articles
• Prevention of activation of blood coagulation during acute coronary ischemic syndromes beyond aspirin and heparin  Journal Articles
• Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone  Journal Articles
• Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness  Journal Articles
• Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double‐blind trial  Journal Articles
• Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation  Journal Articles
• Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic stroke  Journal Articles
• Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines  Journal Articles
• Pro: “Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation”  Journal Articles
• Probenecid Inhibits Platelet Responses to Aggregating Agents in Vitro and Has a Synergistic Inhibitory Effect with Penicillin G  Journal Articles
• Proton Pump Inhibitors and Clopidogrel – Hazardous Drug Interaction or Hazardous Interpretation of Data?  Journal Articles
• Proton pump inhibitor and clopidogrel interaction: The case for watchful waiting  Journal Articles
• Prévention des complications vasculaires après ischémie cérébrale d'origine artérielle. Étude ESPRIT: anticoagulation modérée, association aspirine-dipyridamole ou aspirine seule ?  Journal Articles
• Quality of Anticoagulation Control in Preventing Adverse Events in Patients With Heart Failure in Sinus Rhythm  Journal Articles
• Randomised trials of secondary prevention programmes in coronary heart disease: systematic review  Journal Articles
• Randomized Trials to Assess the Long-term Effects of Therapies on Angiographic End Points  Journal Articles
• Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation  Journal Articles
• Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non–ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: Results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial  Journal Articles
• Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study  Journal Articles
• Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)  Journal Articles
• Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events  Journal Articles
• Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment  Journal Articles
• Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention  Journal Articles
• Rationale and design of the PeriOperative ISchemic Evaluation-2 (POISE-2) trial: An international 2 × 2 factorial randomized controlled trial of acetyl-salicylic acid vs placebo and clonidine vs placebo in patients undergoing noncardiac surgery  Journal Articles
• Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)  Journal Articles
• Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study  Journal Articles
• Re: Anticoagulation and Antiplatelet Therapy in Urological Practice: ICUD/AUA Review Paper: D. J. Culkin, E. J. Exaire, D. Green, M. S. Soloway, A. J. Gross, M. R. Desai, J. R. White and D. J. Lightner J Urol 2014; 192: 1026-1034  Journal Articles
• Recent Safety Concerns With Proton Pump Inhibitors  Journal Articles
• Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation  Journal Articles
• Relation between clopidogrel active metabolite levels and different platelet aggregation methods in patients receiving clopidogrel and aspirin  Journal Articles
• Relationship Between Degree of Left Ventricular Dysfunction, Symptom Status, and Risk of Embolic Events in Patients With Atrial Fibrillation and Heart Failure  Journal Articles
• Relationship of Activated Partial Thromboplastin Time to Coronary Events and Bleeding in Patients With Acute Coronary Syndromes Who Receive Heparin  Journal Articles
• Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates  Journal Articles
• Renal function and outcomes in acute coronary syndrome: impact of clopidogrel  Journal Articles
• Reply  Journal Articles
• Resource Use and Costs of Treatment With Anticoagulation and Antiplatelet Agents: Results of the WATCH Trial Economic Evaluation  Journal Articles
• Response  Journal Articles
• Response by Bagai et al to Letter Regarding Article, “Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention”  Journal Articles
• Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies  Journal Articles
• Results of the COMPASS Trial Analyzed Using Win Ratio Compared With Conventional Analytic Approaches  Journal Articles
• Retinal vein thrombosis: The Internist's role in the etiologic and therapeutic management  Journal Articles
• Reversal of the anti‐platelet effects of aspirin and clopidogrel  Journal Articles
• Reversing Anticoagulant Therapy  Journal Articles
• Review of aspirin and clopidogrel resistance in peripheral arterial disease  Journal Articles
• Review: After PCI with DESs, long- and standard-term DAPT increase some adverse outcomes vs short-term DAPT  Journal Articles
• Risk Profile and 1-Year Outcome of Newly Diagnosed Atrial Fibrillation in Japan　― Insights From GARFIELD-AF ―  Journal Articles
• Risk factor documentation in elective and emergency vascular surgical admissions  Journal Articles
• Risk factors for MACE and bleeding in atrial fibrillation patients undergoing surgery: Insights from the bridge trial  Journal Articles
• Risk of Death and Cardiovascular Events in Initially Healthy Women With New-Onset Atrial Fibrillation  Journal Articles
• Risk of Intracranial Hemorrhage Associated With Direct Oral Anticoagulation vs Antiplatelet Therapy: A Systematic Review and Meta-Analysis.  Journal Articles
• Risk of recurrent venous thromboembolism according to baseline risk factor profiles  Journal Articles
• Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk  Journal Articles
• Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis  Journal Articles
• Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD  Journal Articles
• Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial  Journal Articles
• Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease  Journal Articles
• Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease  Journal Articles
• Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization  Journal Articles
• Rivaroxaban and Aspirin in Peripheral Vascular Disease: a Review of Implementation Strategies and Management of Common Clinical Scenarios  Journal Articles
• Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization  Journal Articles
• Rivaroxaban for Patients with Intermittent Claudication.  Journal Articles
• Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline  Journal Articles
• Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source  Journal Articles
• Rivaroxaban for the Prevention of Major Adverse Cardiovascular Events in Patients with Coronary or Peripheral Artery Disease  Journal Articles
• Rivaroxaban in Peripheral Artery Disease after Revascularization  Journal Articles
• Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits  Journal Articles
• Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism  Journal Articles
• Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial  Journal Articles
• Rivaroxaban plus aspirin after lower-extremity revascularization.  Journal Articles
• Rivaroxaban plus aspirin for cardiovascular protection: Rationale for the vascular dose and dual pathway inhibition  Journal Articles
• Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial  Journal Articles
• Rivaroxaban versus aspirin on functional and cognitive outcomes after embolic stroke of undetermined source: NAVIGATE ESUS trial  Journal Articles
• Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arterial Disease and Intermittent Claudication. Rationale and Design of the COMPASS CLAUDICATION Trial  Journal Articles
• Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease  Journal Articles
• Rivaroxaban with or without aspirin for prevention of cardiovascular disease  Journal Articles
• Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial  Journal Articles
• Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial  Journal Articles
• Rivaroxaban, in combination with low-dose aspirin, is associated with a reduction in proinflammatory and prothrombotic circulating vesicle signatures in patients with cardiovascular disease.  Journal Articles
• Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease  Journal Articles
• Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents  Journal Articles
• Routine Early Angioplasty after Fibrinolysis for Acute Myocardial Infarction  Journal Articles
• Routine aspiration thrombectomy improves the diagnosis and management of embolic myocardial infarction.  Journal Articles
• Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials.  Journal Articles
• Routine vs Selective Invasive Strategies in Acute Coronary Syndromes  Journal Articles
• Safer anticoagulant therapy after heart valve replacement  Journal Articles
• Safety and efficacy of ginkgo (Ginkgo biloba) during pregnancy and lactation.  Journal Articles
• Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin  Journal Articles
• Secondary Prevention Medications in 17 Countries Grouped by Income Level (PURE): A Prospective Cohort Study.  Journal Articles
• Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS)  Journal Articles
• Secondary prevention of venous thromboembolism  Journal Articles
• Sex‐Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD  Journal Articles
• Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention  Journal Articles
• Simultaneous measurement of adenosine triphosphate release and aggregation potentiates human platelet aggregation responses for some subjects, including persons with Quebec platelet disorder  Journal Articles
• Single or Dual Antiplatelet Treatment after TAVI  Journal Articles
• Standardized Bleeding Definitions for Cardiovascular Clinical Trials  Journal Articles
• State of the Art-A Journey through the World of Antithrombotic Therapy  Journal Articles
• State-of-the-Art Mini Review: Dual-Pathway Inhibition to Reduce Arterial and Venous Thromboembolism  Journal Articles
• Stent thrombosis in the setting of ST-segment elevation acute myocardial infarction in the contemporary practice: results from the TOTAL randomized trial.  Journal Articles
• Stroke Prevention in Nonvalvular Atrial Fibrillation  Journal Articles
• Stroke‐prevention strategies in North American patients with atrial fibrillation: The GLORIA‐AF registry program  Journal Articles
• Structure and function of a perioperative anticoagulation management clinic  Journal Articles
• Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease  Journal Articles
• Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale  Journal Articles
• TIPS to decide whether to prescribe aspirin for the primary prevention of cardiovascular events in chronic kidney disease  Journal Articles
• Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes  Journal Articles
• Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes  Journal Articles
• Tetrandrine differentially inhibits aggregation and ATP-release of rat platelets.  Journal Articles
• The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy  Journal Articles
• The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease  Journal Articles
• The Cost of Clopidogrel Use in Atrial Fibrillation in the ACTIVE-A Trial  Journal Articles
• The Editor's Roundtable: Arterial Thrombosis and Acute Coronary Syndromes  Journal Articles
• The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients  Journal Articles
• The Evolution of Antiplatelet Therapy After Percutaneous Coronary Interventions: A 40-Year Journey  Journal Articles
• The FAST-MI 2005-2010-2015 registries in the light of the COMPASS trial: The COMPASS criteria applied to a post-MI population  Journal Articles
• The Fat-Mass and Obesity-Associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women  Journal Articles
• The Interaction Between Proton Pump Inhibitors and Clopidogrel and Upper Gastrointestinal Bleeding  Journal Articles
• The Optimal Anti-Coagulation for Enhanced-Risk Patients Post–Catheter Ablation for Atrial Fibrillation (OCEAN) trial  Journal Articles
• The Perioperative Management of Antithrombotic Therapy  Journal Articles
• The Pursuit of Clinically Relevant Measures of Platelet Function After Antiplatelet Drug Therapy⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.  Journal Articles
• The Relative Efficacy and Safety of Clopidogrel in Women and Men  Journal Articles
• The Secondary Prevention of Small Subcortical Strokes (SPS3) Study  Journal Articles
• The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines  Journal Articles
• The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines Executive Summary  Journal Articles
• The Use of Platelet Function Assays May Help to Determine Appropriate Antiplatelet Treatment Options in a Patient With Recurrent Stroke on Baby Aspirin  Journal Articles
• The Warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): rationale, design, and baseline patient characteristics  Journal Articles
• The aspirin controversy in primary prevention  Journal Articles
• The beginning of the end of warfarin?  Journal Articles
• The blood compatibility challenge. Part 1: Blood-contacting medical devices: The scope of the problem  Journal Articles
• The cost implications of a polypill for primary prevention in the TIPS-3 trial  Journal Articles
• The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study.  Journal Articles
• The effect of antiplatelet therapy on survival and cardiac allograft vasculopathy following heart transplantation: A systematic review and meta‐analysis  Journal Articles
• The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies  Journal Articles
• The effects of oral anticoagulants in patients with peripheral arterial disease: Rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials  Journal Articles
• The evolving treatment of peripheral arterial disease: preventing ischaemic events in the post-COMPASS era  Journal Articles
• The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians  Journal Articles
• The need to test the theories behind the Polypill: rationale behind the Indian Polycap Study  Journal Articles
• The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect  Journal Articles
• The polypill: from concept and evidence to implementation  Journal Articles
• The predictive value of interarm systolic blood pressure differences in patients with vascular disease: Sub-analysis of the COMPASS trial  Journal Articles
• The reemergence of aspirin for the prevention of venous thromboembolism.  Journal Articles
• The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study  Journal Articles
• The role of platelets and platelet inhibition in acute myocardial infarction  Journal Articles
• The significance of new onset atrial fibrillation complicating acute myocardial infarction  Journal Articles
• The use of glycoprotein IIb/IIIa receptor inhibitors in unstable angina.  Journal Articles
• Therapeutic strategies for thrombosis: new targets and approaches  Journal Articles
• Therapy for triggered acute risk prevention in subjects at increased cardiovascular risk.  Journal Articles
• There seems to be a low risk of experiencing postoperative bleeding in patients undergoing dental extractions or minor oral surgery who continue using antiplatelet therapy  Journal Articles
• Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors  Journal Articles
• Thromboembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment in the ACTIVE trials  Journal Articles
• Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators.  Journal Articles
• Thromboprophylaxis practice patterns in hip fracture surgery patients: experience in Perth, Western Australia  Journal Articles
• Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial  Journal Articles
• Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis  Journal Articles
• Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study  Journal Articles
• Timing of Antiplatelet Resumption After Intracerebral Hemorrhage: A Sophie’s Choice  Journal Articles
• Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin  Journal Articles
• To anticoagulate? Controversy in the management of thrombotic complications of head & neck infections  Journal Articles
• Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial  Journal Articles
• Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 1: Which form of aspirin is the fastest to inhibit platelet aggregation in emergency department patients with non-ST segment elevation myocardial infarction?  Journal Articles
• Treating Patients With Acute Coronary Syndromes With Aggressive Antiplatelet Therapy (from the Global Registry of Acute Coronary Events)  Journal Articles
• Treatment of Acute Coronary Syndromes  Journal Articles
• Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non–ST-elevation acute coronary syndrome patients: The Canadian Global Registry of Acute Coronary Events (GRACE) experience  Journal Articles
• Unexpected Effects of Aurin Tricarboxylic Acid on Human Platelets  Journal Articles
• Unstable Angina and Non–ST-Elevation Myocardial Infarction  Journal Articles
• Unstable angina.  Journal Articles
• Unstable angina.  Journal Articles
• Urinary thromboxane and risk of cardiovascular events: role of aspirin  Journal Articles
• Use of Alternative Medicines by Patients with OA that Adversely Interact with Commonly Prescribed Medications  Journal Articles
• Use of Clopidogrel Post-Coronary Artery Bypass Surgery in Canadian Patients With Acute Coronary Syndromes  Journal Articles
• Use of Heparins in Non-ST-Elevation Acute Coronary Syndromes  Journal Articles
• Use of genetic data to guide therapy in arterial disease  Journal Articles
• Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey  Journal Articles
• Use of the Pipeline Shield in the Posterior Circulation with Single Antiplatelet Therapy: A Case of Delayed In-stent Thrombosis  Journal Articles
• Validity of Composite Outcomes in Meta-Analyses of Stroke Prevention Trials: The Case of Aspirin  Journal Articles
• Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy  Journal Articles
• Vascular access and antiplatelet therapies: does one influence the other?  Journal Articles
• Vascular viewpoint  Journal Articles
• Vorapaxar in the Secondary Prevention of Atherothrombotic Events  Journal Articles
• Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial  Journal Articles
• Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm  Journal Articles
• Warfarin in Heart Failure  Journal Articles
• What do the results of the PRoFESS trial teach us?  Journal Articles
• When guidelines collide  Journal Articles
• Which Risk Factors Are More Associated With Ischemic Stroke Than Intracerebral Hemorrhage in Patients With Atrial Fibrillation?  Journal Articles
• Will prasugrel supersede clopidogrel for acute coronary syndromes?  Journal Articles
• Xarelto plus Acetylsalicylic acid: Treatment patterns and Outcomes in patients with Atherosclerosis (XATOA): Rationale and design of a prospective registry study to assess rivaroxaban 2.5 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, peripheral artery disease, or both  Journal Articles
• [Prevention of vascular complications following cerebral ischemia of arterial origin; the ESPRIT trial: mild anticoagulant therapy, combination treatment with acetylsalicylic acid plus dipyridamole or treatment with acetylsalicylic acid alone?].  Journal Articles